AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CVS GROUP PLC

Share Issue/Capital Change Feb 6, 2015

7590_rns_2015-02-06_1d8d3ef8-4d26-47cf-af15-232884f2a747.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2709E

CVS Group plc

06 February 2015

6 February 2015

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, the UK's leading provider of integrated veterinary services, announces that on 5 February 2015 it approved the issue and allotment of 595 new ordinary shares of 0.2p each in the Company ("Ordinary Shares") (the "New Shares") following the exercise of certain Save As You Earn options by a former CVS employee. The New Shares are not covered by the Company's existing block listing arrangements and therefore application has been made for admission of the New Shares to trading on AIM and dealings are expected to commence on 11 February 2015 ("Admission").

In addition, 16,974 Ordinary Shares have today been issued as a result of the exercise of employee share options, under the Company's Block Admission for its 2011/2014 Save as You Earn scheme (the "SAYE Shares").

The New Shares and the SAYE Shares will rank pari passu with all existing Ordinary Shares.

Following Admission of the New Shares and the issue of the SAYE Shares, the Company's total issued share capital will consist of 59,170,366 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following Admission, the total number of voting rights in the Company will be 59,170,366. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Nick Perrin, Finance Director
Tel: 01379 644 288
N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell

Alex Wright
Tel: 020 7496 3000

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCBBGDDGBGBGUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.